News
- 2024.08.09 Therapeutics Mechanism of UnicoCell's New Drug ELIXCYTE® Has Been Published Internationally
- 2024.08.06 UnicoCell Biomed Concludes Phase 1/2 Chronic Kidney Disease Trial
- 2024.05.21 UnicoCell Biomed (6794) was Publicly Listed on Taiwan Innovation Board
- 2024.05.14 UnicoCell has passed the onsite inspection of cell processing facility from Japan MHLW (Ministry of Health, Labor and Welfare)
- 2024.04.18 UnicoCell Biomed held a Pre-IPO Investor Conference on the TIB (Taiwan Innovation Board)
- 2024.02.17 The stem cell new drug, ELIXCYTE, honored by the international journal Cytotherapy acceptance
Products & services
